VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Boston Immune Technologies & Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Pioneering novel TNFR superfamily antagonists

  • Biotech & therapeutics
Status
Operatingas of 2026-09-23Source (opens in a new tab)
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies

About the company

Status notes
Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy